Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Study finds unexpected new drug target for acute myeloid leukemia

Study finds unexpected new drug target for acute myeloid leukemia

High levels of natural immune suppressor in leukemia patients linked to poor survival

High levels of natural immune suppressor in leukemia patients linked to poor survival

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Powering up fat cells could help acute myeloid leukemia patients

Powering up fat cells could help acute myeloid leukemia patients

Newly discovered compound causes cancer cell death, whilst sparing healthy cells

Newly discovered compound causes cancer cell death, whilst sparing healthy cells

New treatment approach makes cancer cells commit suicide while sparing healthy cells

New treatment approach makes cancer cells commit suicide while sparing healthy cells

New research uncovers how blood cancer 'steals' parts of bone marrow cells to thrive

New research uncovers how blood cancer 'steals' parts of bone marrow cells to thrive

Trial identifies genetic fault that affects treatment response in leukemia patients

Trial identifies genetic fault that affects treatment response in leukemia patients

Modified blood thinner may be first promising method to prevent repercussions after TBI

Modified blood thinner may be first promising method to prevent repercussions after TBI

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Spot Leukaemia campaign launched to reduce delays in diagnosis

Spot Leukaemia campaign launched to reduce delays in diagnosis

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Researchers trace origins of AML relapse to rare therapy-resistant stem cells

Researchers trace origins of AML relapse to rare therapy-resistant stem cells

PNNL-OHSU scientists part of NCI effort to study about role of proteins in cancer biology

PNNL-OHSU scientists part of NCI effort to study about role of proteins in cancer biology

Researchers discover how mutations in protein network drive high-risk leukemias

Researchers discover how mutations in protein network drive high-risk leukemias